Interaction of wild type and dominant-negative p55(PIK) regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins

Molecular Endocrinology

Volumn 11, Issue 13, 1997, Pages 1911-1923

  Mothe, Isabelle ^a   Delahaye, Laurent ^a   Filloux, Chantal ^a   Pons, Sebastian ^b   White, Morris F ^b   Van Obberghen, Emmanuel ^a  

^a INSERM   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SUBUNIT; SOMATOMEDIN C; WORTMANNIN;

ANIMAL CELL; ARTICLE; ENZYME SUBUNIT; FEEDBACK SYSTEM; GLUCOSE TRANSPORT; HORMONE RECEPTOR INTERACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030784680     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.13.0029     Document Type: Article

References (44)

1. Whitman M, Downes CP, Keeler M, Keller T, Cantley L 1988 Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 322:644-646
2. Dhand R, Hiles I, Panayotou G, Roche S, Fry MG, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, Kasuga M, Courtneidge SA, Waterfield MD 1994 PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein serine kinase activity. EMBO J 13:522-533
3. 3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 83:821-830
4. Yao R, Cooper GM 1995 Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006
5. Kotani K, Yonezawa K, Hara K, Ueda H, Kitamura Y, Sakaue H, Ando A, Chavanieu A, Calas B, Grigorescu F, Nishiyama M, Waterfield MD, Kasuga M 1994 Involvement of phosphoinositide 3-kinase in insulin-or IGF-1-induced membrane ruffling. EMBO J 13:2313-2321
6. S6k activation by phosphatidylinositol-3-OH kinase. Nature 370:71-75
7. Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky JM 1996 Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 271:17605-17608
8. Katagiri H, Asano T, Ishihara H, Inukai K, Shibasaki Y, Kikuchi M, Yazaki Y, Oka Y 1996 Overexpression of catalytic subunit p110α of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem 271:16987-16990
9. Tanti JF, Grémeaux T, Grillo S, Calleja V, Klippel A, Williams LT, Van Obberghen E, Le Marchand-Brustel Y 1996 Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut4 translocation in adipocytes. J Biol Chem 271: 25227-25232
10. Panayotou G, Bax B, Gout I, Federwish M, Wroblowski B, Dhand R, Fry MJ, Blundell TL, Wollmer A, Waterfield MD 1992 Interaction of the p85 subunit of PI-3 kinase ans its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. EMBO J 11:4261-4272
11. Shoelson SE, Sivaraja M, Williams KP, Hu P, Schlessinger J, Weiss MA 1993 Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation. EMBO J 12:795-802
12. PIK is generated by alternative splicing of the p85α gene. J Biol Chem 271:5317-5320
13. Antonetti DA, Algenstaedt P, Kahn CR 1996 Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol Cell Biol 16:2195-2203
14. PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 15:4453-4465
15. LeRoith D, Werner H, Beitner-Johnson D, Roberts CTJ 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
16. Giorgetti S, Ballotti R, Kowalski-Chauvel A, Tartare S, Van Obberghen E 1993 The insulin and insulin-like growth factor-1 receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem 268:7358-7364
17. Altschuler D, Yamamoto K, Lapetina EG 1994 Insulin-like growth factor-I mediated association of p85 phosphatidylinositol 3-kinase with pp185: requirement of SH2 domains for in vivo interaction. Mol Endocrinol 8:1139-1146
18. Yamamoto K, Altschuler D, Wood E, Horlick K, Jacobs S, Lapetina EG 1992 Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J Biol Chem 16: 11337-11343
19. Seely BL, Reichart DR, Staubs PS, Jhun BH, Hsu D, Maegawa H, Milarski KL, Saltiel AR, Olefsky JM 1995 Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J Biol Chem 270:19151-19157
20. Tartare-Deckert S, Murdaca J, Sawka-Verhelle D, Holt KH, Pessin JE, Van Obberghen E 1996 Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF-1) receptor: comparative study using the yeast two-hybrid system. Endocrinology 137:1019-1024
21. Lamothe B, Bucchini D, Jami J, Joshi RL 1995 Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system. FEBS Lett 373:51-55
22. Torres-Aleman I, Pons S, Arevalo MA 1994 The insulin-like growth factor-1 system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation. J Neurosci Res 39:117-126
23. Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E 1995 Evidence for a differential interaction of Shc and the insulin receptor substrate 1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. J Biol Chem 270:23456-23460
24. Sawka-Verhelle D, Tartare-Deckert S, White MF, Van Obberghen E 1996 Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J Biol Chem 271:5980-5983
25. Rocchi S, Tartare-Deckert S, Sawka-Verhelle D, Gamha A, Van Obberghen E 1996 Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system. Endocrinology 137:4944-4952
26. Wilden PA, Kahn CR, Siddle K, White MF 1992 Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem 267: 16660-16668
27. Gronborg M, Wulf BS, Rasmussen JS, Kjeldsen T, Gammeltoft S 1993 Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J Biol Chem 268:23435-23440
28. Kato H, Faria TN, Stannard B, Roberts CT, LeRoith D 1994 Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-1) receptor in IGF-1 action. Mol Endocrinol 8:40-50
29. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonozawa K, Kasuga M, Waterfield MD 1994 PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J 13:511-521
30. Holt KH, Olson AN, Scott Moye-Rowley W, Pessin JE 1994 Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits. Mol Cell Biol 14:42-49
31. Yonezawa K, Yokono K, Shii K, Ogawa W, Ando A, Hara K, Baba S, Kaburagi Y, Yamamoto-Honda R, Momomura K, Kadowaki T, Kasuga M 1992 In vitro association of phosphatidylinositol 3-kinase activity with the activated insulin receptor tyrosine kinase. J Biol Chem 267:440-446
32. Carpenter CL, Auger KR, Chanudhuri M, Yoakim M, Schaffhausen B, Shoelson S, Cantley LC 1993 Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem 268:9478-9483
33. Herbst JJ, Andrews G, Contillo L, Lamphere L, Gardner J, Lienhard GE, Gibbs EM 1994 Potent activation of phosphatidylinositol 3′-kinase by single phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry 33:9376-9381
34. Heller-Harrison RA, Morin M, Guilherme A, Czech MP 1996 Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J Biol Chem 271:10200-10204
35. Quon MJ, Chen H, Ing BL, Liu M-L, Zarnowski MJ, Yonezawa K, Kasuga M, Cushman SW, Taylor SI 1995 Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cell Biol 15:5403-5411
36. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL 1994 The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. J Biol Chem 269:20648-20652
37. Tanti J-F, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y 1994 Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304:17-21
38. Tanti J-F, Grémeaux T, Van Obberghen E, Le Marchand-Brustel Y 1994 Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057
39. Mothe I, Van Obberghen E 1996 Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 271:11222-11227
40. Gietz D, St. Jean A, Woods RA, Schiestl RH 1992 Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425-1426
41. Bartel PL, Chien C, Sternglanz R, Fields S 1993 Using the two hybrid system to detect protein-protein interactions. In: Hartley DA (ed) Cellular Interactions in Development: A Practical Approach. Oxford University Press, Oxford, UK, pp 153-179
42. Miller JH 1972 Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 633-640
43. Cormont M, Tanti J-F, Zahraoui A, Van Obberghen E, Tavitian A, Le Marchand-Brustel Y 1993 Insulin and okadaic acid induce Rab4 redistribution in adipocytes. J Biol Chem 268:19491-19497
44. Chen C, Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752